{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T23:14:52Z","timestamp":1768605292044,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hebei Province","award":["C2025405060"],"award-info":[{"award-number":["C2025405060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04335-9","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T02:05:39Z","timestamp":1767578739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSPA8 is a biomarker associated with prognosis and immunity in skin cutaneous melanoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Weizheng","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruzhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taixing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rensen","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"5","key":"4335_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160.","journal-title":"JAMA Dermatol"},{"issue":"8","key":"4335_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2174\/1874467217666230329102030","volume":"16","author":"T Zhao","year":"2023","unstructured":"Zhao T, Guo M, Chen H, et al. IDO2-siRNA carried by Salmonella combined with Nifuroxazide attenuates melanoma growth. Curr Mol Pharmacol. 2023;16(8):881\u201393. https:\/\/doi.org\/10.2174\/1874467217666230329102030.","journal-title":"Curr Mol Pharmacol"},{"issue":"10400","key":"4335_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, et al. Cutaneous melanoma. Lancet. 2023;402(10400):485\u2013502. https:\/\/doi.org\/10.1016\/s0140-6736(23)00821-8.","journal-title":"Lancet"},{"key":"4335_CR4","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429259562230925055749","volume":"17","author":"L Liang","year":"2024","unstructured":"Liang L, Li Y, Jiao Y, et al. Maprotiline prompts an antitumour effect by inhibiting PD-L1 expression in mice with melanoma. Curr Mol Pharmacol. 2024;17:e18761429259562. https:\/\/doi.org\/10.2174\/0118761429259562230925055749.","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"4335_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA: a cancer journal for clinicians"},{"issue":"6","key":"4335_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/ijc.31527","volume":"143","author":"M Arnold","year":"2018","unstructured":"Arnold M, de Vries E, Whiteman DC, et al. Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer. 2018;143(6):1305\u201314. https:\/\/doi.org\/10.1002\/ijc.31527.","journal-title":"Int J Cancer"},{"key":"4335_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329\u201360. https:\/\/doi.org\/10.1146\/annurev.immunol.22.012703.104803.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"4335_CR8","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.4161\/auto.26448","volume":"9","author":"F Stricher","year":"2013","unstructured":"Stricher F, Macri C, Ruff M, et al. HSPA8\/HSC70 chaperone protein: structure, function, and chemical targeting. Autophagy. 2013;9(12):1937\u201354. https:\/\/doi.org\/10.4161\/auto.26448.","journal-title":"Autophagy"},{"key":"4335_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040601","author":"K Zhao","year":"2023","unstructured":"Zhao K, Zhou G, Liu Y, et al. HSP70 family in cancer: signaling mechanisms and therapeutic advances. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13040601.","journal-title":"Biomolecules"},{"issue":"6","key":"4335_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167827","volume":"1871","author":"A Ruzza","year":"2025","unstructured":"Ruzza A, Zaltron E, Vianello F, et al. HSPA8 and HSPA9: two prognostic and therapeutic targets in breast, colon, and kidney cancers? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025;1871(6):167827. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167827.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"3","key":"4335_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306535","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Ming H, Qin S, et al. HSPA8 activates Wnt\/\u03b2-catenin signaling to facilitate BRAF V600E colorectal cancer progression by CMA-mediated CAV1 degradation. Adv Sci. 2024;11(3):e2306535. https:\/\/doi.org\/10.1002\/advs.202306535.","journal-title":"Adv Sci"},{"issue":"12","key":"4335_CR12","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.4049\/jimmunol.1401417","volume":"193","author":"RJ Binder","year":"2014","unstructured":"Binder RJ. Functions of heat shock proteins in pathways of the innate and adaptive immune system. J Immunol (Baltimore Md: 1950). 2014;193(12):5765\u201371. https:\/\/doi.org\/10.4049\/jimmunol.1401417.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"1","key":"4335_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, et al. EMT: 2016. Cell. 2016;166(1):21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028.","journal-title":"Cell"},{"issue":"4","key":"4335_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J, Papadogeorgakis E, Hill L, et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. 2013;24(4):466\u201380. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.018.","journal-title":"Cancer Cell"},{"issue":"14","key":"4335_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/onc.2013.128","volume":"33","author":"H Zheng","year":"2014","unstructured":"Zheng H, Kang Y. Multilayer control of the EMT master regulators. Oncogene. 2014;33(14):1755\u201363. https:\/\/doi.org\/10.1038\/onc.2013.128.","journal-title":"Oncogene"},{"key":"4335_CR16","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks. Front Immunol. 2023;14:1212476. https:\/\/doi.org\/10.3389\/fimmu.2023.1212476.","journal-title":"Front Immunol"},{"issue":"2","key":"4335_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.Cd-22-0876","volume":"13","author":"C Falcomat\u00e0","year":"2023","unstructured":"Falcomat\u00e0 C, B\u00e4rthel S, Schneider G, et al. Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer. Cancer Discov. 2023;13(2):278\u201397. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-0876.","journal-title":"Cancer Discov"},{"issue":"8","key":"4335_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1003466.","journal-title":"N Engl J Med"},{"issue":"2","key":"4335_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400-e1611. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.","journal-title":"Cell"},{"issue":"43","key":"4335_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4335_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.15","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Dunn P, Thomas CG, et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Scientific data. 2018. https:\/\/doi.org\/10.1038\/sdata.2018.15.","journal-title":"Scientific data."},{"issue":"4","key":"4335_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Pont\u00e9n","year":"2008","unstructured":"Pont\u00e9n F, Jirstr\u00f6m K, Uhlen M. The human protein atlas\u2013a tool for pathology. J Pathol. 2008;216(4):387\u201393. https:\/\/doi.org\/10.1002\/path.2440.","journal-title":"J Pathol"},{"issue":"D1","key":"4335_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"269","key":"4335_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"key":"4335_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13072-015-0014-8","volume":"8","author":"A D\u00edez-Villanueva","year":"2015","unstructured":"D\u00edez-Villanueva A, Mallona I, Peinado MA. Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer. Epigenetics Chromatin. 2015;8:22. https:\/\/doi.org\/10.1186\/s13072-015-0014-8.","journal-title":"Epigenetics Chromatin"},{"issue":"1","key":"4335_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Ge D, Lu C. The SMART app: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics Chromatin. 2019;12(1):71. https:\/\/doi.org\/10.1186\/s13072-019-0316-3.","journal-title":"Epigenetics Chromatin"},{"issue":"7","key":"4335_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u201382. https:\/\/doi.org\/10.1038\/s41587-019-0114-2.","journal-title":"Nat Biotechnol"},{"issue":"21","key":"4335_CR28","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX, et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411.","journal-title":"Bioinformatics"},{"issue":"9","key":"4335_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/17460441.2016.1216967","volume":"11","author":"S Kim","year":"2016","unstructured":"Kim S. Getting the most out of pubchem for virtual screening. Expert Opin Drug Discov. 2016;11(9):843\u201355. https:\/\/doi.org\/10.1080\/17460441.2016.1216967.","journal-title":"Expert Opin Drug Discov"},{"issue":"D1","key":"4335_CR30","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt: the Universal Protein Knowledgebase in 2023","year":"2023","unstructured":"UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u201331. https:\/\/doi.org\/10.1093\/nar\/gkac1052.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4335_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235\u201342. https:\/\/doi.org\/10.1093\/nar\/28.1.235.","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"4335_CR32","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3967\/bes2025.124","volume":"38","author":"CY Hou","year":"2025","unstructured":"Hou CY, Wang P, Yan FX, et al. NFKBIE: novel biomarkers for Diagnosis, Prognosis, and immunity in colorectal cancer: insights from Pan-cancer analysis. Biomed Environ Sci: BES. 2025;38(10):1320\u20135. https:\/\/doi.org\/10.3967\/bes2025.124.","journal-title":"Biomed Environ Sci: BES"},{"key":"4335_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126395","author":"S Strashilov","year":"2021","unstructured":"Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22126395.","journal-title":"Int J Mol Sci"},{"issue":"39","key":"4335_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2426981122","volume":"122","author":"R Ran","year":"2025","unstructured":"Ran R, Li L, Chen P, et al. Versatile Xenopus tropicalis model with targeted integration of human BRAF(V600E). Proc Natl Acad Sci U S A. 2025;122(39):e2426981122. https:\/\/doi.org\/10.1073\/pnas.2426981122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4335_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050590","author":"AB Hua","year":"2019","unstructured":"Hua AB, Justiniano R, Perer J, et al. Repurposing the electron transfer reactant phenazine methosulfate (PMS) for the apoptotic elimination of malignant melanoma cells through induction of lethal oxidative and mitochondriotoxic stress. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11050590.","journal-title":"Cancers"},{"key":"4335_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijbiomac.2020.12.146","volume":"170","author":"SJ Yin","year":"2021","unstructured":"Yin SJ, Lee JR, Hahn MJ, et al. Tyrosinase-mediated melanogenesis in melanoma cells: array comparative genome hybridization integrating proteomics and bioinformatics studies. Int J Biol Macromol. 2021;170:150\u201363. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.146.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"4335_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ccell.2016.04.013","volume":"29","author":"M Cerezo","year":"2016","unstructured":"Cerezo M, Lehraiki A, Millet A, et al. Compounds triggering ER stress exert anti-melanoma effects and overcome BRAF inhibitor resistance. Cancer Cell. 2016;29(6):805\u201319. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.013.","journal-title":"Cancer Cell"},{"issue":"36","key":"4335_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403019","volume":"11","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yu B, Sheng C, et al. SHISA3 reprograms tumor-associated macrophages toward an antitumoral phenotype and enhances cancer immunotherapy. Adv Sci. 2024;11(36):e2403019. https:\/\/doi.org\/10.1002\/advs.202403019.","journal-title":"Adv Sci"},{"key":"4335_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1166860","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Xiang S, Pan W, et al. Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: current research and future perspective. Front Oncol. 2023;13:1166860. https:\/\/doi.org\/10.3389\/fonc.2023.1166860.","journal-title":"Front Oncol"},{"issue":"4","key":"4335_CR40","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3892\/or.2018.6254","volume":"39","author":"A Benedicto","year":"2018","unstructured":"Benedicto A, Romayor I, Arteta B. Cxcr4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. Oncol Rep. 2018;39(4):2022\u201330. https:\/\/doi.org\/10.3892\/or.2018.6254.","journal-title":"Oncol Rep"},{"issue":"2","key":"4335_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","volume":"19","author":"M Quante","year":"2011","unstructured":"Quante M, Tu SP, Tomita H, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19(2):257\u201372. https:\/\/doi.org\/10.1016\/j.ccr.2011.01.020.","journal-title":"Cancer Cell"},{"key":"4335_CR42","doi-asserted-by":"publisher","first-page":"217389","DOI":"10.1016\/j.canlet.2024.217389","volume":"611","author":"P Liu","year":"2024","unstructured":"Liu P, Gao X, Yu Z, et al. H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression. Cancer Lett. 2024;611:217389. https:\/\/doi.org\/10.1016\/j.canlet.2024.217389.","journal-title":"Cancer Lett"},{"issue":"1","key":"4335_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02390-w","volume":"10","author":"P Gao","year":"2025","unstructured":"Gao P, Zuo C, Yuan W, et al. Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer. Signal Transduct Target Ther. 2025;10(1):313. https:\/\/doi.org\/10.1038\/s41392-025-02390-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4335_CR44","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/gutjnl-2021-326581","volume":"72","author":"Y Fan","year":"2023","unstructured":"Fan Y, Li Y, Yao X, et al. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. Gut. 2023;72(4):624\u201337. https:\/\/doi.org\/10.1136\/gutjnl-2021-326581.","journal-title":"Gut"},{"key":"4335_CR45","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Wang Z, Ding Y, et al. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14:1133308. https:\/\/doi.org\/10.3389\/fimmu.2023.1133308.","journal-title":"Front Immunol"},{"issue":"6","key":"4335_CR46","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/ijc.34559","volume":"153","author":"N Dalpatraj","year":"2023","unstructured":"Dalpatraj N, Naik A, Thakur N. GSK-J4: an H3K27 histone demethylase inhibitor, as a potential anti-cancer agent. Int J Cancer. 2023;153(6):1130\u20138. https:\/\/doi.org\/10.1002\/ijc.34559.","journal-title":"Int J Cancer"},{"key":"4335_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109384","volume":"118","author":"X Yin","year":"2019","unstructured":"Yin X, Yang S, Zhang M, et al. The role and prospect of JMJD3 in stem cells and cancer. Biomed Pharmacother. 2019;118:109384. https:\/\/doi.org\/10.1016\/j.biopha.2019.109384.","journal-title":"Biomed Pharmacother"},{"key":"4335_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells13201678","author":"A Romani","year":"2024","unstructured":"Romani A, Lodi G, Casciano F, et al. Enhanced anti-melanoma activity of Nutlin-3a delivered via ethosomes: targeting p53-mediated apoptosis in HT144 cells. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13201678.","journal-title":"Cells"},{"issue":"22","key":"4335_CR49","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1093\/emboj\/20.22.6297","volume":"20","author":"FW King","year":"2001","unstructured":"King FW, Wawrzynow A, H\u00f6hfeld J, et al. Co-chaperones Bag-1, hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J. 2001;20(22):6297\u2013305. https:\/\/doi.org\/10.1093\/emboj\/20.22.6297.","journal-title":"EMBO J"},{"key":"4335_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2025.2576615","author":"M Di Crosta","year":"2025","unstructured":"Di Crosta M, Ragone FC, Benedetti R, et al. Acetylation promotes mutant (MUT) TP53-HSPA8 and HSPA8-BAG3 interactions, facilitating MUT TP53 lysosomal degradation preferentially via CASA. Autophagy. 2025. https:\/\/doi.org\/10.1080\/15548627.2025.2576615.","journal-title":"Autophagy"},{"issue":"1","key":"4335_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2567.2003.01725.x","volume":"110","author":"SM Todryk","year":"2003","unstructured":"Todryk SM, Gough MJ, Pockley AG. Facets of heat shock protein 70 show immunotherapeutic potential. Immunology. 2003;110(1):1\u20139. https:\/\/doi.org\/10.1046\/j.1365-2567.2003.01725.x.","journal-title":"Immunology"},{"issue":"3","key":"4335_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00262-003-0481-9","volume":"53","author":"C Castelli","year":"2004","unstructured":"Castelli C, Rivoltini L, Rini F, et al. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother. 2004;53(3):227\u201333. https:\/\/doi.org\/10.1007\/s00262-003-0481-9.","journal-title":"Cancer Immunol Immunother"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04335-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:59:23Z","timestamp":1768564763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04335-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4335"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04335-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}